GURUFOCUS.COM » STOCK LIST » Basic Materials » Agriculture » MustGrow Biologics Corp (TSXV:MGRO) » Definitions » EPS (Diluted)

MustGrow Biologics (TSXV:MGRO) EPS (Diluted) : C$0.01 (TTM As of Dec. 2023)


View and export this data going back to 2019. Start your Free Trial

What is MustGrow Biologics EPS (Diluted)?

MustGrow Biologics's Earnings per Share (Diluted) for the three months ended in Dec. 2023 was C$0.07. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was C$0.01.

MustGrow Biologics's EPS (Basic) for the three months ended in Dec. 2023 was C$0.07. Its EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2023 was C$0.01.

MustGrow Biologics's EPS without NRI for the three months ended in Dec. 2023 was C$0.07. Its EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2023 was C$0.01.

During the past 3 years, the average EPS without NRIGrowth Rate was 55.90% per year. During the past 5 years, the average EPS without NRI Growth Rate was 24.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 8 years, MustGrow Biologics's highest 3-Year average EPS without NRI Growth Rate was 55.90% per year. The lowest was -291.50% per year. And the median was -22.80% per year.


MustGrow Biologics EPS (Diluted) Historical Data

The historical data trend for MustGrow Biologics's EPS (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MustGrow Biologics EPS (Diluted) Chart

MustGrow Biologics Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EPS (Diluted)
Get a 7-Day Free Trial -0.06 -0.09 -0.07 -0.11 -0.01

MustGrow Biologics Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Sep23 Dec23
EPS (Diluted) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.04 -0.02 -0.02 -0.04 0.07

Competitive Comparison of MustGrow Biologics's EPS (Diluted)

For the Agricultural Inputs subindustry, MustGrow Biologics's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


MustGrow Biologics's PE Ratio Distribution in the Agriculture Industry

For the Agriculture industry and Basic Materials sector, MustGrow Biologics's PE Ratio distribution charts can be found below:

* The bar in red indicates where MustGrow Biologics's PE Ratio falls into.



MustGrow Biologics EPS (Diluted) Calculation

EPS (Diluted) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Diluted EPS takes into account all of the outstanding dilutive securities that could potentially be exercised (such as stock options and convertible preferred stock) and shows how such an action would impact earnings per share.

MustGrow Biologics's Diluted EPS for the fiscal year that ended in Dec. 2023 is calculated as

Diluted EPS (A: Dec. 2023 ) = (Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(-0.677-0)/49.895
=-0.01

MustGrow Biologics's Diluted EPS for the quarter that ended in Dec. 2023 is calculated as

Diluted EPS (Q: Dec. 2023 )=(Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(3.431-0)/50.322
=0.07

EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.01

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


MustGrow Biologics  (TSXV:MGRO) EPS (Diluted) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


MustGrow Biologics EPS (Diluted) Related Terms

Thank you for viewing the detailed overview of MustGrow Biologics's EPS (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.


MustGrow Biologics (TSXV:MGRO) Business Description

Traded in Other Exchanges
Address
1005 - 201 1st Avenue South, Saskatoon, SK, CAN, S7K 1J5
MustGrow Biologics Corp is a company engaged in the development of natural biopesticide products from mustard seed. It is focused on the development and commercialization of non-synthetic AITC (Allyl Isothiocyanate) from mustard seed for use as a natural biofumigant for the control of nematodes, soil-borne diseases, and other soil pests.

MustGrow Biologics (TSXV:MGRO) Headlines

No Headlines